0.4666
Precedente Chiudi:
$0.477
Aprire:
$0.4844
Volume 24 ore:
729.88K
Relative Volume:
0.12
Capitalizzazione di mercato:
$24.17M
Reddito:
-
Utile/perdita netta:
$-563.30K
Rapporto P/E:
-2.3377
EPS:
-0.1996
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
-8.51%
1M Prestazione:
+10.05%
6M Prestazione:
-24.01%
1 anno Prestazione:
-55.13%
Promis Neurosciences Inc Stock (PMN) Company Profile
Nome
Promis Neurosciences Inc
Settore
Industria
Telefono
416-847-6898
Indirizzo
SUITE 200, 1920 YONGE STREET, TORONTO
Confronta PMN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PMN
Promis Neurosciences Inc
|
0.4666 | 24.70M | 0 | -563.30K | -22.23M | -0.1996 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
Is ProMIS Neurosciences Inc. stock safe for conservative investorsProduct Launch & Fast Exit and Entry Strategy Plans - newser.com
What MACD and RSI say about ProMIS Neurosciences Inc.2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Custom watchlist performance reports with ProMIS Neurosciences Inc.2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
What to expect from ProMIS Neurosciences Inc. in the next 30 daysTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock sustain uptrend momentumTrade Risk Summary & Short-Term High Return Ideas - newser.com
Can technical indicators confirm ProMIS Neurosciences Inc.’s reversalTrade Volume Summary & Growth Focused Stock Reports - newser.com
Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Custom strategy builders for tracking ProMIS Neurosciences Inc.Earnings Overview Report & Precise Trade Entry Recommendations - newser.com
How high can ProMIS Neurosciences Inc. stock go2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Using data models to predict ProMIS Neurosciences Inc. stock movement2025 Momentum Check & Smart Swing Trading Techniques - newser.com
How hedge fund analytics apply to ProMIS Neurosciences Inc. stockGDP Growth & Weekly High Conviction Trade Ideas - newser.com
Can ProMIS Neurosciences Inc. (23J0) stock surprise with quarterly resultsQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
ProMIS Neurosciences Amends Employment Agreement with CSO - MSN
ProMIS Neurosciences Stock (PMN) Opinions on Alzheimer’s Candidate Fast Track Designation - Quiver Quantitative
Milbury Max a buys ProMis Neurosciences (PMN) shares worth $14928 - Investing.com
Will ProMIS Neurosciences Inc. (23J0) stock beat value stocksQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Automated trading signals detected on ProMIS Neurosciences Inc.Trade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Predicting ProMIS Neurosciences Inc. trend using moving averages2025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
What drives ProMIS Neurosciences Inc stock priceHealthcare Stock Analysis & Get Alerts on Stocks Set to Skyrocket - earlytimes.in
ProMIS Neurosciences Inc 23J0 Stock Analysis and ForecastPortfolio Allocation Tips & Exceptional Return Investment - earlytimes.in
Volume spikes in ProMIS Neurosciences Inc. stock – what they meanWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Promis Neurosciences Inc Azioni (PMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Promis Neurosciences Inc Azioni (PMN) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Cashman Neil | Chief Scientific Officer |
Feb 10 '25 |
Buy |
0.97 |
15,000 |
14,595 |
16,617 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):